2006
30
Nov
Pfizer Says Diet Drug Set for Phase III Trials Could Compete With … - Acomplia Report
| Pfizer Says Diet Drug Set for Phase III Trials Could Compete With … Acomplia Report, Fl - 30th that two of its experimental obesity drugs appeared to be as effective for weight loss as the Sanofi-Aventis diet drug Acomplia (rimonabant). … |
More: continued here